Ketamine to reduce postpartum depression and pain after cesarean delivery
Funded at Utah State Higher Education System--University of Utah · NIH-11509433 · Data updated 2026-11-12
This grant explores a ketamine approach to help new mothers after cesarean delivery feel better sooner and with less pain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State Higher Education System--University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | July 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $611,254 |
| NIH project number | 7R01MH134538-04 |
| Project ID | NIH-11509433 on NIH RePORTER |
Who could benefit from this research
✓Could help
Postpartum women who recently had a cesarean delivery and are lactating.
✕Less likely to help
Women not undergoing cesarean delivery or those with contraindications to ketamine may not benefit.
What this research studies
This project looks at giving ketamine to women after cesarean birth to see how it affects pain, mood, and recovery while they are lactating. Researchers will study the drug’s tolerable dose, how it moves through the body, and how it acts in the body after cesarean delivery. The goal is to identify a safe, effective dosing plan that could reduce postpartum depression risk and improve pain control for mothers and support newborn care. Results could inform future trials and clinical care for mothers in the postpartum period.
Why it matters
Potential benefit: If successful, this work could lead to better pain management and mood outcomes for new mothers after cesarean delivery.
How similar studies have gone: Prior small postpartum ketamine studies show mixed safety signals; this study aims to establish tolerable dosing and pharmacokinetics.
Where this research is happening
-
Utah State Higher Education System--University of Utah
Salt Lake City, United States Active
Researchers
- Principal investigator: Lim, Grace — Utah State Higher Education System--University of Utah
- Study coordinator: Lim, Grace
Related research
Other NIH-funded projects on the same topics.
-
Using ketamine to help mothers with depression and pain after cesarean delivery
This study is looking at how ketamine can help new moms feel better by reducing postpartum depression and pain after a cesarean delivery, and it aims to find the best dose to improve their mood and manage pain safely.
-
Group-based postpartum depression prevention: in-person vs. virtual delivery
A large study is testing whether the ROSE group program delivered virtually to pregnant people is just as helpful as the in-person version in preventing postpartum depression.
-
Postpartum depression screening at well-child visits in Arkansas
A study examines whether adding depression screening at baby visits in Arkansas improves detection and care for new mothers.
-
Trajectories of Positive Motivation and Postpartum Depression Risk
This project studies how brain reward function and daily mood patterns before and after birth relate to the risk of postpartum depression, with a focus on mothers and babies.
-
ROSE Scale-Up: Expanding universal postpartum depression prevention for new mothers
A national effort to roll out the ROSE prevention program to all new mothers, to see if universal use can reduce postpartum depression.
-
How Medicaid Postpartum Coverage and PPD Screening Could Improve Diabetes and Blood Pressure Care After Birth
A large NIH grant is studying how extending Medicaid after birth and mandating postpartum depression screening affect care for women with gestational diabetes and pregnancy-related high blood pressure.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.